Vaccines, blood, antisera, toxins and cultures in   Saudi Arabia

Exports In 2022, Saudi Arabia exported $5.45M in Vaccines, blood, antisera, toxins and cultures, making it the 81st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 306th most exported product in Saudi Arabia. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Saudi Arabia are: Lebanon ($1.16M), Kuwait ($1.15M), Switzerland ($764k), United Arab Emirates ($752k), and United States ($696k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Saudi Arabia between 2021 and 2022 were Switzerland ($753k), Denmark ($197k), and Turkey ($77.8k).

Imports In 2022, Saudi Arabia imported $2.02B in Vaccines, blood, antisera, toxins and cultures, becoming the 24th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 8th most imported product in Saudi Arabia. Saudi Arabia imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($646M), Germany ($334M), Switzerland ($291M), United States ($158M), and Netherlands ($114M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Saudi Arabia between 2021 and 2022 were Germany ($63M), Austria ($43.1M), and Switzerland ($32.3M).